Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1992 Jan;33(1):121–123. doi: 10.1111/j.1365-2125.1992.tb04012.x

Lack of effect of ageing on the stereochemical disposition of propranolol.

H H Zhou 1, E Whelan 1, A J Wood 1
PMCID: PMC1381211  PMID: 1540484

Abstract

The elderly are more resistant to the effects of propranolol than the young. To determine whether the decreased sensitivity in the elderly could be due to stereoselective alteration in propranolol metabolism, we investigated the effect of age on the oral clearance of (-)- and (+)-propranolol. Six young (aged 24-32, mean 27.3 +/- 1.3 years) and six elderly (65-80, mean 71.3 +/- 2.7 years) white male volunteers were given a single 80 mg oral dose of racemic propranolol. The mean peak plasma concentrations of both (+)- and (-)-propranolol were significantly higher (P less than 0.05) in the elderly (105.7 +/- 19.7 and 165.0 +/- 29.7 nmol l-1) compared with the young subjects (68.6 +/- 10.1 and 115.7 +/- 18.1 nmol l-1). The oral clearances of both (+)- and (-)-propranolol were significantly higher (P less than 0.05) in the young (6933 +/- 598 and 4554 +/- 372 ml min-1) than in the elderly (4548 +/- 712 and 2941 +/- 473 ml min-1). Age had no effect on the relative concentration of the two isomers. Thus, the ratio of (+)-propranolol to (-)-propranolol was 0.67 +/- 0.05 in the young compared with 0.65 +/- 0.02 in the elderly.

Full text

PDF
121

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Castleden C. M., George C. F. The effect of ageing on the hepatic clearance of propranolol. Br J Clin Pharmacol. 1979 Jan;7(1):49–54. doi: 10.1111/j.1365-2125.1979.tb00896.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Chandler M. H., Scott S. R., Blouin R. A. Age-associated stereoselective alterations in hexobarbital metabolism. Clin Pharmacol Ther. 1988 Apr;43(4):436–441. doi: 10.1038/clpt.1988.55. [DOI] [PubMed] [Google Scholar]
  3. Everitt D. E., Avorn J. Drug prescribing for the elderly. Arch Intern Med. 1986 Dec;146(12):2393–2396. [PubMed] [Google Scholar]
  4. Greenblatt D. J., Sellers E. M., Shader R. I. Drug therapy: drug disposition in old age. N Engl J Med. 1982 May 6;306(18):1081–1088. doi: 10.1056/NEJM198205063061804. [DOI] [PubMed] [Google Scholar]
  5. Hooper W. D., Qing M. S. The influence of age and gender on the stereoselective metabolism and pharmacokinetics of mephobarbital in humans. Clin Pharmacol Ther. 1990 Dec;48(6):633–640. doi: 10.1038/clpt.1990.207. [DOI] [PubMed] [Google Scholar]
  6. Loi C. M., Vestal R. E. Drug metabolism in the elderly. Pharmacol Ther. 1988;36(1):131–149. doi: 10.1016/0163-7258(88)90115-5. [DOI] [PubMed] [Google Scholar]
  7. Murray K. T., Reilly C., Koshakji R. P., Roden D. M., Lineberry M. D., Wood A. J., Siddoway L. A., Barbey J. T., Woosley R. L. Suppression of ventricular arrhythmias in man by d-propranolol independent of beta-adrenergic receptor blockade. J Clin Invest. 1990 Mar;85(3):836–842. doi: 10.1172/JCI114510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Pan H. Y., Hoffman B. B., Pershe R. A., Blaschke T. F. Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man. J Pharmacol Exp Ther. 1986 Dec;239(3):802–807. [PubMed] [Google Scholar]
  9. Prakash C., Koshakji R. P., Wood A. J., Blair I. A. Simultaneous determination of propranolol enantiomers in plasma by high-performance liquid chromatography with fluorescence detection. J Pharm Sci. 1989 Sep;78(9):771–775. doi: 10.1002/jps.2600780915. [DOI] [PubMed] [Google Scholar]
  10. Silber B., Holford N. H., Riegelman S. Stereoselective disposition and glucuronidation of propranolol in humans. J Pharm Sci. 1982 Jun;71(6):699–704. doi: 10.1002/jps.2600710623. [DOI] [PubMed] [Google Scholar]
  11. Vestal R. E., Wood A. J., Branch R. A., Shand D. G., Wilkinson G. R. Effects of age and cigarette smoking on propranolol disposition. Clin Pharmacol Ther. 1979 Jul;26(1):8–15. doi: 10.1002/cpt19792618. [DOI] [PubMed] [Google Scholar]
  12. Vestal R. E., Wood A. J., Shand D. G. Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther. 1979 Aug;26(2):181–186. doi: 10.1002/cpt1979262181. [DOI] [PubMed] [Google Scholar]
  13. Walle T., Byington R. P., Furberg C. D., McIntyre K. M., Vokonas P. S. Biologic determinants of propranolol disposition: results from 1308 patients in the Beta-Blocker Heart Attack Trial. Clin Pharmacol Ther. 1985 Nov;38(5):509–518. doi: 10.1038/clpt.1985.216. [DOI] [PubMed] [Google Scholar]
  14. Wilkinson G. R. Clearance approaches in pharmacology. Pharmacol Rev. 1987 Mar;39(1):1–47. [PubMed] [Google Scholar]
  15. Wood A. J., Vestal R. E., Wilkinson G. R., Branch R. A., Shand D. G. Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination. Clin Pharmacol Ther. 1979 Jul;26(1):16–20. doi: 10.1002/cpt197926116. [DOI] [PubMed] [Google Scholar]
  16. Woodhouse K. W., Wynne H. A. Age-related changes in liver size and hepatic blood flow. The influence on drug metabolism in the elderly. Clin Pharmacokinet. 1988 Nov;15(5):287–294. doi: 10.2165/00003088-198815050-00002. [DOI] [PubMed] [Google Scholar]
  17. Zhou H. H., Wood A. J. Differences in stereoselective disposition of propranolol do not explain sensitivity differences between white and Chinese subjects: correlation between the clearance of (-)- and (+)-propranolol. Clin Pharmacol Ther. 1990 Jun;47(6):719–723. doi: 10.1038/clpt.1990.98. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES